Cargando…
Antitumor Virotherapy by Attenuated Measles Virus (MV)
Antitumor virotherapy consists of the use of replication-competent viruses to infect and kill tumor cells preferentially, without damaging healthy cells. Vaccine-attenuated strains of measles virus (MV) are good candidates for this approach. Attenuated MV uses the CD46 molecule as a major entry rece...
Autores principales: | Guillerme, Jean-Baptiste, Gregoire, Marc, Tangy, Frédéric, Fonteneau, Jean-François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960896/ https://www.ncbi.nlm.nih.gov/pubmed/24832799 http://dx.doi.org/10.3390/biology2020587 |
Ejemplares similares
-
Attenuated measles virus used as an oncolytic virus activates myeloid and plasmacytoid dendritic cells
por: Fonteneau, Jean-François, et al.
Publicado: (2013) -
Natural Oncolytic Activity of Live-Attenuated Measles Virus against Human Lung and Colorectal Adenocarcinomas
por: Boisgerault, Nicolas, et al.
Publicado: (2013) -
Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination
por: Baldo, Aline, et al.
Publicado: (2015) -
Oncolytic measles virus induces tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated cytotoxicity by human myeloid and plasmacytoid dendritic cells
por: Achard, Carole, et al.
Publicado: (2016) -
Oncolytic virotherapy for human malignant mesothelioma: recent advances
por: Boisgerault, Nicolas, et al.
Publicado: (2015)